Update of the decision-making algorithm on selecting transfusion-dependent β-thalassemic patients for gene therapy approaches: joint consensus report on behalf of EHA-specialized working group and EBMT hemoglobinopathies working party.
Expert guidance provides tailored treatment-selection strategies for thalassemia patients, improving individualized care decisions.
β-thalassemia is a globally distributed hereditary red blood cell disorder. This expert opinion provides dynamic, updatable, priority-based guidance for physicians taking care of TDT patients.
What the study was
- Study design
- Consensus guideline
- Population
- Cancer/disease patients
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Bone marrow transplantation
Why it surfaced
Matched topic(s): Rare diseases with high unmet need. Study design: Consensus guideline. Score 7/10.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.